This move is archived. Current quotes and coverage live on the stock page.
Follow VM
Voyageur Pharmaceuticals Ltd is making waves on the TSX Venture Exchange with a staggering 27.27% increase in just one day.
In a remarkable turn of events, Voyageur Pharmaceuticals Ltd (VM.V) has seen its stock price soar by 27.27% in the latest trading session, closing at CA$0.14. This surge is due to significant developments in the company's strategic initiatives aimed at enhancing its position in the pharmaceutical industry.
Advertisement
Voyageur Pharmaceuticals Ltd
VM.V
VM.V
Voyageur Pharmaceuticals Ltd
WealthAwesomeMarket cap
$28.29M
52W high
$0.20
52W low
$0.07
1W change
-10.71%
Beta
0.46
Analyst Price Targets
Based on analyst covering VM · as of Sep 17, 2026
Wall Street analysts forecast VM stock price to rise 340.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.55
+340.0% Upside
Current Price
C$0.13
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VM's historical volatility
30-Day Vol
55.3%
Annualized
90-Day Vol
84.8%
Annualized
Trend (90d)
-32.3%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.12 | C$0.10 – C$0.15 |
| 60 trading days | C$0.12 | C$0.09 – C$0.15 |
| 90 trading days | C$0.11 | C$0.08 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of Voyageur's recent partnerships and feasibility studies, which could pave the way for substantial growth in the medical imaging market.
Voyageur Pharmaceuticals Ltd sees stock surge by 27.27%
With a market cap of CA$25.13 million, the company's recent developments could significantly impact its growth trajectory in the coming years.
Bull case
Voyageur's partnership with Fluor Corporation for feasibility studies shows a strong commitment to developing a vertically integrated supply chain for iodine and barium contrast media. This could position Voyageur as a leader in the North American market.
Bear case
While the stock is on the rise, investors should stay cautious about the risks tied to the feasibility studies and the competitive landscape in the pharmaceutical sector.
Strategic Partnership with Fluor Corporation
Advertisement
Voyageur Pharmaceuticals has teamed up with Fluor Corporation to conduct feasibility studies for two key projects: an iodine extraction facility in Oklahoma and an integrated contrast drug manufacturing plant. This partnership is expected to boost Voyageur's ability to produce high-purity iodine and barium contrast media, which are crucial for medical imaging.
Market Potential and Future Growth
The company's focus on becoming a vertically integrated producer of contrast agents positions it well in a market that increasingly values domestic supply chains. With Health Canada-approved products already generating revenue, Voyageur is on track to capture significant market share in the North American medical imaging sector.
Investor Considerations
While the recent stock performance is promising, investors should weigh the potential risks associated with the feasibility studies and the competitive landscape. Successfully executing these initiatives will be critical for Voyageur's long-term growth and stability in the market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
